Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspective

AIDS. 2021 Dec 15;35(Suppl 2):S153-S163. doi: 10.1097/QAD.0000000000003108.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • HIV Infections* / drug therapy
  • Humans
  • Public Health
  • Treatment Failure
  • Viral Load

Substances

  • Anti-HIV Agents